Percutaneous biofixed medical implants
    2.
    发明授权
    Percutaneous biofixed medical implants 失效
    经皮生物固定医疗植入物

    公开(公告)号:US06299930B1

    公开(公告)日:2001-10-09

    申请号:US09400657

    申请日:1999-09-20

    IPC分类号: B05D300

    摘要: Percutaneous implants are disclosed including a portion implantable into a patient, a dermal bonding region capable of forming a bond between the implant and a dermal layer of the patient after the implantable portion is implanted into the patient, and the dermal bonding region including a substrate with a discontinuous coating of particulate bioactive glass wherein the average spacing between the particles of bioactive glass is predetermined and at least about 20 microns prior to implantation into the patient. Also disclosed are bioactive coatings including a substrate and fibers and/or particles of bioactive glass distributed on the substrate with a predetermined average interfiber distance of at least about 20 microns.

    摘要翻译: 公开了经皮植入物,其包括可植入患者体内的部分,在将可植入部分植入患者体内后能够在植入物和患者真皮层之间形成结合的真皮粘合区域,并且真皮粘合区域包括具有 颗粒生物活性玻璃的不连续涂层,其中生物活性玻璃颗粒之间的平均间距是预定的,并且在植入患者体内之前至少约20微米。 还公开了生物活性涂层,其包括基底和分布在基底上的纤维和/或生物活性玻璃颗粒,其预定平均纤维间距离为至少约20微米。

    Percutaneous biofixed medical implants
    4.
    发明授权
    Percutaneous biofixed medical implants 失效
    经皮生物固定医疗植入物

    公开(公告)号:US5990380A

    公开(公告)日:1999-11-23

    申请号:US948836

    申请日:1997-10-10

    摘要: Percutaneous implants are disclosed including a portion implantable into a patient, a dermal bonding region capable of forming a bond between the implant and a dermal layer of the patient after the implantable portion is implanted into the patient, and the dermal bonding region including a substrate with a discontinuous coating of particulate bioactive glass wherein the average spacing between the particles of bioactive glass is predetermined and at least about 20 microns prior to implantation into the patient. Also disclosed are bioactive coatings including a substrate and fibers and/or particles of bioactive glass distributed on the substrate with a predetermined average interfiber distance of at least about 20 microns.

    摘要翻译: 公开了经皮植入物,其包括可植入患者体内的部分,在将可植入部分植入患者体内后能够在植入物和患者真皮层之间形成结合的真皮粘合区域,并且真皮粘合区域包括具有 颗粒生物活性玻璃的不连续涂层,其中生物活性玻璃颗粒之间的平均间距是预定的,并且在植入患者体内之前至少约20微米。 还公开了生物活性涂层,其包括基底和分布在基底上的纤维和/或生物活性玻璃颗粒,其预定平均纤维间距离为至少约20微米。

    Percutaneous delivery system for treatment of osteonecrosis of the hip and methods of use thereof
    5.
    发明授权
    Percutaneous delivery system for treatment of osteonecrosis of the hip and methods of use thereof 有权
    用于治疗髋关节骨坏死的经皮递送系统及其使用方法

    公开(公告)号:US08092452B2

    公开(公告)日:2012-01-10

    申请号:US11751321

    申请日:2007-05-21

    IPC分类号: A61B17/56

    CPC分类号: A61M31/002

    摘要: Systems, methods, and carriers for percutaneous delivery of growth factors to treat osteonecrosis in the hip and other locations are disclosed. A rolled carrier comprising a biphasic ceramic rolled by a collagen sponge, and carrying a growth factor, are inserted via a delivery tube or cannula into a pre-formed hole in bone without overstuffing of the carrier or growth factor.

    摘要翻译: 公开了用于经皮递送生长因子以治疗髋部和其他位置的骨坏死的系统,方法和载体。 包括由胶原海绵滚动并携带生长因子的双相陶瓷的滚动载体通过输送管或插管插入到骨中的预先形成的孔中,而不会过载载体或生长因子。

    PERCUTANEOUS DELIVERY SYSTEM FOR TREATMENT OF OSTEONECROSIS OF THE HIP AND METHODS OF USE THEREOF
    6.
    发明申请
    PERCUTANEOUS DELIVERY SYSTEM FOR TREATMENT OF OSTEONECROSIS OF THE HIP AND METHODS OF USE THEREOF 有权
    用于治疗呕吐的骨质疏松症的PERCUTANEOUS递送系统及其使用方法

    公开(公告)号:US20080294085A1

    公开(公告)日:2008-11-27

    申请号:US11751321

    申请日:2007-05-21

    IPC分类号: A61M31/00

    CPC分类号: A61M31/002

    摘要: Systems, methods, and carriers for percutaneous delivery of growth factors to treat osteonecrosis in the hip and other locations are disclosed. A rolled carrier comprising a biphasic ceramic rolled by a collagen sponge, and carrying a growth factor, are inserted via a delivery tube or cannula into a pre-formed hole in bone without overstuffing of the carrier or growth factor.

    摘要翻译: 公开了用于经皮递送生长因子以治疗髋部和其他位置的骨坏死的系统,方法和载体。 包括由胶原海绵滚动并携带生长因子的双相陶瓷的滚动载体通过输送管或插管插入到骨中的预先形成的孔中,而不会过载载体或生长因子。

    Surface modified silicone drug depot
    8.
    发明授权
    Surface modified silicone drug depot 失效
    表面改性硅酮药剂库

    公开(公告)号:US06274159B1

    公开(公告)日:2001-08-14

    申请号:US09429396

    申请日:1999-10-28

    IPC分类号: A61F202

    摘要: An improved implantable pharmaceutical depot for the prolonged release of at least one biologically active substance, the depot comprising a polymeric carrier and the biologically active substance, the improvement wherein the depot is coated or surface modified with a biologically active and biocompatible glass, glass-ceramic or ceramic material, the coating or modified surface being capable of forming a bond to soft tissue upon implantation. Methods for forming the biologically active and biocompatible glass, glass-ceramic or ceramic coating or modified surface on the silicone based depot are also disclosed.

    摘要翻译: 用于延长释放至少一种生物活性物质的改进的可植入药物贮库,所述贮存库包含聚合物载体和所述生物活性物质,其改进在于使用生物活性和生物相容性玻璃,玻璃陶瓷 或陶瓷材料,所述涂层或改性表面能够在植入时与软组织形成结合。 还公开了在硅氧烷基储存库上形成生物活性和生物相容性玻璃,玻璃陶瓷或陶瓷涂层或改性表面的方法。